Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center
Current Oncology · 2023
DOI: 10.3390/curroncol30050366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Prarthna V Bhardwaj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, University of Massachusetts Chan Medical School-Baystate, 759 Chestnut Street, Springfield, MA 01199 , USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The utilization of neoadjuvant chemotherapy (NAC) remains highly variable in clinical practice. The implementation of NAC requires coordination of handoffs between a multidisciplinary team (MDT). This study aims to assess the outcomes of an MDT in the management of early-stage breast cancer patients undergoing neoadjuvant chemotherapy at a community cancer center.
Methods
We conducted a retrospective case series on patients receiving NAC for early-stage operable or locally advanced breast cancer coordinated by an MDT. Outcomes of interest included the rate of downstaging of cancer in the breast and axilla, time from biopsy to NAC, time from completion of NAC to surgery, and time from surgery to radiation therapy (RT).
Results
Ninety-four patients underwent NAC; 84% were White and mean age was 56.5 yrs. Of them, 87 (92.5%) had clinical stage II or III cancer, and 43 (45.8%) had positive lymph nodes. Thirty-nine patients (42.9%) were triple negative, 28 (30.8%) were human epidermal growth factor receptor (HER-2)+, and 24 (26.2%) were estrogen receptor (ER) +HER-2−. Of 91 patients, 23 (25.3%) achieved pCR; 84 patients (91.4%) had downstaging of the breast tumor, and 30 (33%) had axillary downstaging. The median time from diagnosis to NAC was 37.5 days, the time from completion of NAC to surgery was 29 days, and the time from surgery to RT was 49.5 days.
Conclusions
Our MDT provided timely, coordinated, and consistent care for patients with early-stage breast cancer undergoing NAC as evidenced by time to treatment outcomes consistent with recommended national trends.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology-Oncology, University of Massachusetts Chan Medical School-Baystate, 759 Chestnut Street, Springfield, MA 01199 , USA.
- Breast Surgery Section, University of Massachusetts Chan Medical School-Baystate, 759 Chestnut Street, Springfield, MA 01199, USA.
- Division of Radiation Oncology, University of Massachusetts Chan Medical School-Baystate, 759 Chestnut Street, Springfield, MA 01199, USA.
- Institute for Healthcare Delivery and Population Science, University of Massachusetts Chan Medical-Baystate, 759 Chestnut Street, Springfield, MA 01199, USA.
ORCID-Profile: Holly Mason
Zitieren
APA
Bhardwaj, P. V., Mason, H., Kaufman, S. A., Visintainer, P., & Makari-Judson, G. (2023). Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center. Current Oncology. https://doi.org/10.3390/curroncol30050366
Vancouver
Bhardwaj PV, Mason H, Kaufman SA, Visintainer P, Makari-Judson G. Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center. Current Oncology. 2023. doi:10.3390/curroncol30050366
BibTeX
@article{Bhardwaj2023,
author = {Bhardwaj, Prarthna V and Mason, Holly and Kaufman, Seth A and Visintainer, Paul and Makari-Judson, Grace},
title = {Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30050366}
}
EUVIMED